改良帽辅助内镜下黏膜切除术与内镜黏膜下剥离术治疗≤10 mm直肠神经内分泌肿瘤的随机非劣效性试验
本研究为随机非劣效性试验,比较改良帽辅助内镜下黏膜切除术(mEMR-C)与内镜黏膜下剥离术(ESD)治疗≤10 mm直肠神经内分泌肿瘤(NET)的安全性和疗效。最终分析79例病理确诊的直肠NET患者(mEMR-C组38例,ESD组41例),组织学完全切除率mEMR-C组为97.4%,ESD组为92.7%,绝对差值为4.7%(双侧90%置信区间,-3.3%至12.2%;P=0.616),证实mEMR-C非劣效于ESD。mEMR-C组手术时间更短(8.89±4.58 vs 24.8±9.14分钟,P<0.05),住院费用更低($2,233.76±$717.70 vs $2,987.27±$871.81,P<0.05)。
要点
- mEMR-C治疗≤10 mm直肠NET的组织学完全切除率非劣效于ESD。
- mEMR-C组手术时间(8.89±4.58分钟)短于ESD组(24.8±9.14分钟)。
- mEMR-C组住院费用($2,233.76±$717.70)低于ESD组($2,987.27±$871.81)。
核心结论
- mEMR-C非劣效于ESD,两者完全切除率相似,且mEMR-C手术时间更短、住院费用更低。
研究设计与样本
- 随机非劣效性试验,纳入90例患者,最终分析79例病理确诊的直肠NET患者,其中mEMR-C组38例,ESD组41例。
主要发现
- 组织学完全切除率mEMR-C组为97.4%,ESD组为92.7%,绝对差值为4.7%(双侧90%置信区间,-3.3%至12.2%;P=0.616)。
- 所有患者均实现整块切除和直肠NET成功切除。
- 手术时间mEMR-C组为8.89±4.58分钟,ESD组为24.8±9.14分钟(P<0.05)。
- 住院费用mEMR-C组为$2,233.76±$717.70,ESD组为$2,987.27±$871.81(P<0.05)。
- 术后并发症mEMR-C组4例(11.5%),ESD组2例(4.9%)(P=0.509),均经内镜处理良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although recent guidelines recommend endoscopic resection of rectal neuroendocrine tumors (NET) ≤10 mm, there is no consensus on which endoscopic modality should be performed. We aimed to compare the safety and efficacy of modified cap-assisted endoscopic mucosal resection (mEMR-C) and endoscopic submucosal dissection (ESD) methods for the treatment of rectal NET ≤10 mm. METHODS: A randomized noninferiority trial comparing mEMR-C and ESD was conducted. The primary outcome was the histological complete resection rate; the secondary outcomes included en bloc resection rate, operation time, complications, and so on. Subgroup analyses and follow-up were also performed. RESULTS: Ninety patients were enrolled, and 79 patients with pathologically confirmed rectal NET were finally analyzed, including 38 cases of mEMR-C and 41 cases of ESD. Histological complete resection rate was 97.4% in the mEMR-C group and 92.7% in the ESD group. The noninferiority of mEMR-C compared with that of ESD was confirmed because the absolute difference was 4.7% (2-sided 90% confidence interval, -3.3% to 12.2%; P = 0.616). En bloc resection and successful removal of rectal NET were achieved in all patients. Advantages of mEMR-C over ESD included shorter operation time (8.89 ± 4.58 vs 24.8 ± 9.14 minutes, P < 0.05) and lower hospitalization cost ($2,233.76 ± $717.70 vs $2,987.27 ± $871.81, P < 0.05). Postoperative complications were recorded in 4 patients who received mEMR-C and 2 patients in the ESD group (11.5% vs 4.9%, P = 0.509), which were all well managed using endoscopy. Similar findings were observed when subgroup analysis was performed. DISCUSSION: mEMR-C is noninferior to ESD with a similar complete resection rate. In addition, mEMR-C had shorter procedure duration time and lower hospitalization costs. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03982264.
引用
- Gao X, Huang S, Wang Y, et al. Modified Cap-Assisted Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Rectal Neuroendocrine Tumors ≤10 mm: A Randomized Noninferiority Trial. Am J Gastroenterol. 2022. PMID: 36455222. doi:10.14309/ajg.0000000000001914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。